Biotechnology

Biotechnology Pharmaceuticals Genetic Engineering Market Performance Clinical Trials Business Strategy Drug Development Pharmaceutical Technology Drug Efficacy Investment

5 ARTICLES

last mo.

Samsung Biologics Announces Spin-Off of Biosimilar Unit to Form Samsung Epis Holdings

The restructuring aims to sharpen strategic focus, address client concerns, and enhance shareholder value with a clear timeline for completion by October 2025.

3 ARTICLES

last mo.

Pfizer Secures $6 Billion Licensing Deal for Chinese Cancer Drug SSGJ-707

3 ARTICLES

last mo.

Novo Nordisk Partners with Septerna in $2.2 Billion Deal for Oral Obesity Therapies

3 ARTICLES

3mo ago

AstraZeneca Acquires Belgian Biotech EsoBiotec in $1 Billion Deal